No Data
3 Penny Stocks to Watch Now, 12/4/25
BTIG Maintains Jasper Therapeutics(JSPR.US) With Buy Rating, Maintains Target Price $7
RBC Capital Maintains Jasper Therapeutics(JSPR.US) With Hold Rating, Maintains Target Price $4
Analysts Conflicted on These Healthcare Names: Jasper Therapeutics (JSPR) and Azitra Inc (AZTR)
William Blair Maintains Jasper Therapeutics(JSPR.US) With Hold Rating
Jasper Therapeutics: Strategic Patient Selection and Consistent Drug Performance Justify Buy Rating